APA (7th ed.) Citation

Carlisle, J. W., Pentz, R. D., & Ramalingam, S. S. (2024). Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC. Journal of thoracic oncology, 19(11), 1509-1511. https://doi.org/10.1016/j.jtho.2024.08.023

Chicago Style (17th ed.) Citation

Carlisle, Jennifer W., Rebecca D. Pentz, and Suresh S. Ramalingam. "Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC." Journal of Thoracic Oncology 19, no. 11 (2024): 1509-1511. https://doi.org/10.1016/j.jtho.2024.08.023.

MLA (9th ed.) Citation

Carlisle, Jennifer W., et al. "Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC." Journal of Thoracic Oncology, vol. 19, no. 11, 2024, pp. 1509-1511, https://doi.org/10.1016/j.jtho.2024.08.023.